Libero da leggere

Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors

Tanja Dolinsek

Tanja Dolinsek

Cerca questo autore su
Sciendo|Google Scholar
Dolinsek, Tanja
, 
Lara Prosen

Lara Prosen

Cerca questo autore su
Sciendo|Google Scholar
Prosen, Lara
, 
Maja Cemazar

Maja Cemazar

Cerca questo autore su
Sciendo|Google Scholar
Cemazar, Maja
, 
Tjasa Potocnik

Tjasa Potocnik

Cerca questo autore su
Sciendo|Google Scholar
Potocnik, Tjasa
 e 
Gregor Sersa

Gregor Sersa

Cerca questo autore su
Sciendo|Google Scholar
Sersa, Gregor
  
19 lug 2016
Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Research Article
Pubblicato online: 19 lug 2016
Pagine: 274 - 279
Ricevuto: 23 mag 2016
Accettato: 14 giu 2016
DOI: https://doi.org/10.1515/raon-2016-0042
Parole chiave
© 2016 Fazekas and Porvázsnyik, published by De Gruyter Open
This content is free.

Figure 1

Survival of melanoma cells after vemurafenib (VMF) treatment. Survival of (A) BRAF V600E mutated melanoma cells SK-MEL-28 and (B) non-mutated melanoma cells CHL-1.
Survival of melanoma cells after vemurafenib (VMF) treatment. Survival of (A) BRAF V600E mutated melanoma cells SK-MEL-28 and (B) non-mutated melanoma cells CHL-1.

Figure 2

Survival of BRAF V600E mutated SK-MEL-28 melanoma cells and non-mutated CHL-1 cells after ECT with bleomycin. BLM (bleomycin); BLM + EP (ECT with bleomycin). Dotted line represents the IC90 value.
Survival of BRAF V600E mutated SK-MEL-28 melanoma cells and non-mutated CHL-1 cells after ECT with bleomycin. BLM (bleomycin); BLM + EP (ECT with bleomycin). Dotted line represents the IC90 value.

Figure 3

Survival of BRAF V600E mutated SK-MEL-28 melanoma cells after concomitant treatment with ECT and vemurafenib. BLM (bleomycin); BLM + VMF (bleomycin and 0.5 pM vemurafenib); BLM + EP (ECT with bleomycin); BLM + EP + VMF (ECT with bleomycin and 0.5 pM vemurafenib). Dotted line represents the IC90 value.
Survival of BRAF V600E mutated SK-MEL-28 melanoma cells after concomitant treatment with ECT and vemurafenib. BLM (bleomycin); BLM + VMF (bleomycin and 0.5 pM vemurafenib); BLM + EP (ECT with bleomycin); BLM + EP + VMF (ECT with bleomycin and 0.5 pM vemurafenib). Dotted line represents the IC90 value.
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia
Feed RSS della rivista